BC
BRKR icon

Bayforest Capital’s Bruker BRKR Stock Holding History

Bayforest Capital’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,075
Closed -$127K – 748
2025
Q2 		$127K Buy
3,075
+1,669
+119% +$64.5K 0.06% 440
2025
Q1 		$58.7K Buy
+1,406
New +$73.2K 0.03% 544

Other funds holding BRKR

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

Bayforest Capital's BRKR Position: Q3 2025 in Review

Bayforest Capital sold out of Bruker (BRKR) in Q3 2025, closing a stake of 3,075 shares — an estimated $127K sold.

Bayforest Capital first reported a position in BRKR in Q1 2025 and held it in 2 quarters. The position peaked at $127K in Q2 2025. 339 funds tracked by Wall St. Rank hold BRKR as of Q3 2025.

  • Bayforest Capital reported no remaining Bruker position as of Q3 2025 after selling out during the quarter.
  • Bayforest Capital sold 3,075 Bruker shares in Q3 2025, an estimated $127K.
  • Bayforest Capital first reported a position in Bruker in Q1 2025 and held it in 2 quarters.
  • Bayforest Capital's Bruker position peaked at $127K in Q2 2025.
  • 339 funds tracked by Wall St. Rank held Bruker as of Q3 2025.

Based on Bayforest Capital's 13F filing for Q3 2025, filed 24 Oct 2025.